Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Buy
69
ISRG Quote, Financials, Valuation and Earnings
Last price:
$562.00
Seasonality move
:
4.25%
Day range:
$565.77 - $573.28
52-week range:
$425.00 - $616.00
Dividend yield:
0%
P/E ratio:
74.96x
P/S ratio:
21.42x
P/B ratio:
11.86x
Volume:
992.6K
Avg. volume:
1.6M
1-year change:
8.51%
Market cap:
$200.8B
Revenue:
$8.4B
EPS (TTM):
$7.56
Analysts' Opinion
-
Consensus RatingIntuitive Surgical, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 14 Buy ratings, 11 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $599.60, Intuitive Surgical, Inc. has an estimated upside of 5.87% from its current price of $566.36.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $378.00 representing 100% downside risk from its current price of $566.36.
Fair Value
-
According to the consensus of 26 analysts, Intuitive Surgical, Inc. has 5.87% upside to fair value with a price target of $599.60 per share.
ISRG vs. S&P 500
-
Over the past 5 trading days, Intuitive Surgical, Inc. has underperformed the S&P 500 by -0.69% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Intuitive Surgical, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Intuitive Surgical, Inc. has grown year-over-year revenues for 20 quarters straight. In the most recent quarter Intuitive Surgical, Inc. reported revenues of $2.5B.
Earnings Growth
-
Intuitive Surgical, Inc. has grown year-over-year earnings for 11 quarters straight. In the most recent quarter Intuitive Surgical, Inc. reported earnings per share of $1.95.
Enterprise value:
196B
EV / Invested capital:
--
Price / LTM sales:
21.42x
EV / EBIT:
69.59x
EV / Revenue:
20.39x
PEG ratio (5yr expected):
3.50x
EV / Free cash flow:
86.28x
Price / Operating cash flow:
90.67x
Enterprise value / EBITDA:
57.69x
Gross Profit (TTM):
$6.4B
Return On Assets:
14.51%
Net Income Margin (TTM):
28.77%
Return On Equity:
16.38%
Return On Invested Capital:
16.35%
Operating Margin:
30.33%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $6.9B | $7.9B | $9.6B | $2B | $2.5B | |
| Gross Profit | $4.6B | $5.3B | $6.4B | $1.4B | $1.7B | |
| Operating Income | $1.7B | $2.1B | $2.8B | $577.3M | $759.7M | |
| EBITDA | $2.1B | $2.5B | $3.4B | $693.5M | $919.7M | |
| Diluted EPS | $4.25 | $6.22 | $7.56 | $1.56 | $1.95 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $5.7B | $6.3B | $8.9B | $7.2B | $8.5B | |
| Total Assets | $12.9B | $13.3B | $14.7B | $17.7B | $19.4B | |
| Current Liabilities | $1B | $1.2B | $1.7B | $1.7B | $1.8B | |
| Total Liabilities | $1.5B | $1.7B | $2.1B | $2.1B | $2.3B | |
| Total Equity | $11.5B | $11.6B | $12.6B | $15.7B | $17B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2B | $1.8B | $3B | $706.5M | $841M | |
| Cash From Investing | $1.3B | -$3.1B | -$389M | -$1.4B | $401M | |
| Cash From Financing | -$1.2B | $70M | -$2.2B | $98.2M | -$1.8B | |
| Free Cash Flow | $1.3B | $586M | $2.3B | $458.6M | $735.6M | |
ISRG
Sector
Market Cap
$200.8B
$28.1M
Price % of 52-Week High
91.94%
50%
Dividend Yield
0%
0%
Shareholder Yield
1.11%
-1.54%
1-Year Price Total Return
8.51%
-17.67%
Beta (5-Year)
1.669
0.503
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$574.87
200-day SMA
Buy
Level
$510.97
Bollinger Bands (100)
Buy
Level
451.59 - 560.67
Chaikin Money Flow
Buy
Level
1.1B
20-day SMA
Buy
Level
$565.81
Relative Strength Index (RSI14)
Buy
Level
52.22
ADX Line
Buy
Level
23.67
Williams %R
Neutral
Level
-37.347
50-day SMA
Buy
Level
$557.59
MACD (12, 26)
Buy
Level
6.03
25-day Aroon Oscillator
Buy
Level
24
On Balance Volume
Neutral
Level
1.1B
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (50.0688)
Buy
CA Score
(Annual)
Level (2.0199)
Buy
Beneish M-Score
(Annual)
Level (-2.5144)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-6.1156)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.
Stock Forecast FAQ
In the current month, ISRG has received 14 Buy ratings 11 Hold ratings, and 1 Sell ratings. The ISRG average analyst price target in the past 3 months is $599.60.
-
Where Will Intuitive Surgical, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Intuitive Surgical, Inc. share price will rise to $599.60 per share over the next 12 months.
-
What Do Analysts Say About Intuitive Surgical, Inc.?
Analysts are divided on their view about Intuitive Surgical, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Intuitive Surgical, Inc. is a Sell and believe this share price will drop from its current level to $378.00.
-
What Is Intuitive Surgical, Inc.'s Price Target?
The price target for Intuitive Surgical, Inc. over the next 1-year time period is forecast to be $599.60 according to 26 Wall Street analysts, 14 of them rate the stock a Buy, 1 rates the stock a Sell, and 11 analysts rate the stock a Hold.
-
Is ISRG A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Intuitive Surgical, Inc. is a Buy. 14 of 26 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ISRG?
You can purchase shares of Intuitive Surgical, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Intuitive Surgical, Inc. shares.
-
What Is The Intuitive Surgical, Inc. Share Price Today?
Intuitive Surgical, Inc. was last trading at $562.00 per share. This represents the most recent stock quote for Intuitive Surgical, Inc.. Yesterday, Intuitive Surgical, Inc. closed at $566.36 per share.
-
How To Buy Intuitive Surgical, Inc. Stock Online?
In order to purchase Intuitive Surgical, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get ISRG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ISRG
Sector
P/E ratio
74.96x
23.88x
PEG ratio
3.50x
-0.01x
P/B ratio
11.86x
1.82x
Price / LTM sales
21.42x
1.59x
Growth Metrics
ISRG
Sector
Revenue growth
22.91%
4.73%
Earnings growth
24.96%
11.11%
Revenue (5-year growth)
13.28%
6.46%
Earnings forecast
$2.25
-$0.18
Profitability
ISRG
Sector
Profitability FY 2024
$5.6B
$3.6M
Return on invested capital
16.35%
-31.77%
Return on assets
14.51%
-28.18%
Return on equity
16.38%
-37.47%
Earnings Date
Last Earnings Date
Oct
21
Next Earnings Date
Jan
22
Estimated Next Earnings Date
Jan
20
Balance Sheet
ISRG
Sector
Total cash
$4.9B
$26.3M
Short term investments
$2B
$26M
Total assets
$18.8B
$76.9M
Long term debt
--
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
45
CTEV alert for Jan 2
Claritev Corp. [CTEV] is down 20.7% over the past day.
Sell
47
ASTS alert for Jan 2
AST Spacemobile, Inc. [ASTS] is up 14.94% over the past day.
Sell
45
BIDU alert for Jan 2
Baidu, Inc. [BIDU] is up 15.01% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
